Female athletes at risk for gender-related injuries
Women have different sports medicine needs than men.In sports medicine, it isn’t always true that what’s “good for the goose is good for the gander.” Reporting on issues unique to female runners in the journal Physical Medicine and Rehabilitation Clinics of North America, Washington University physical medicine and rehabilitation specialists say women’s bodies adapt to athletic challenges differently. They say that when female athletes get injured, health-care professionals need to consider the anatomic, biomechanical, hormonal and functional factors that are unique to women.
$16 million grant advances nanomedicine at Washington University
Nanoparticles attached to fibers in a blood clotNano-sized particles developed at the School of Medicine offer hope of replacing numerous medical tests, scans, or surgeries with a simple injection. The tiny spheres can travel through the bloodstream deep into the body to locate and highlight tumors undetectable by typical methods. While at the tumor site, the nanoparticles can deliver therapeutic agents to destroy the tumor.
Corbetta named Stupp professor of neurology
The professor of anatomy and neurobiology and of radiology is a leader in research into techniques for rehabilitating the brain after strokes.
Heart patient survival varies greatly with genetic variation
“We were able to associate risk of death with the characteristics of the patients’ beta-adrenergic receptor genes,” says study co-author Howard McLeod.
Greasing interferon’s gears may pave way to greater benefits, fewer side effects
Interferon — a critical protein that mediates the body’s defense against a wide variety of infectious agents and tumors — may soon have greater therapeutic value as the result of a new study by researchers at the School of Medicine.
Secrets to antibody’s success against West Nile Virus surprise scientists
A monoclonal antibody that can effectively treat mice infected with West Nile virus has an intriguing secret: Contrary to scientists’ expectations, it does not block the virus’s ability to attach to host cells. Instead, the antibody somehow stops the infectious process at a later point.
Survival of heart patients on beta-blockers varies greatly with genetic variation
Survival of heart attack and unstable angina patients placed on beta-blocker therapy corresponds to specific variations in their genes, according to a study by researchers at the School of Medicine and the Mid America Heart Institute in Kansas City.
Celebrating in style
Photo by Robert BostonGuests socialize during the Sept. 16 opening celebration of the Farrell Learning and Teaching Center on the Medical Campus.
Once-a-day AIDS meds in Third World nations to be tested
“This is the largest systematic trial of AIDS treatment to ever be conducted on a multinational stage,” David B. Clifford says.
More medical news
Siteman opens cancer center at Barnes-Jewish St. Peters
High-caliber cancer services are now more proximate to the people of St. Charles and its surrounding communities.
View More Stories